Articles By This Author
Keyshia Cole Celebrates With Hunxho At His 25th Birthday Party
Well, well, well, roommates! Keyshia Cole appears to still be head over heels for rapper Hunxho. The ‘Love’ singer popped out
dexter: original sin: Dexter: Original Sin – Dexter prequel release date, plot, behind the scenes and cast
“Dexter: Original Sin” emerges as the latest installment in the enduring saga of everyone’s favorite TV serial killer, Dexter Morgan,
OTC-GEMSF Acquires Historic Rare Earths Project with Reported 226 g/t Gallium, 2.38% Neodymium and 0.93% Gadolinium, Seeks North American Government Funding
Vancouver, Canada, June 21, 2024 –(PR.com)– Infinity Stone Ventures Corp. (OTC:GEMSF) (FSE:B2I) (the “Company” or “Infinity Stone”) announces today the acquisition
Israeli Official Describes Secret Government Bid to Cement Control of West Bank
An influential member of Prime Minister Benjamin Netanyahu’s coalition told settlers in the Israeli-occupied West Bank that the government is
Torras Companies Mourn the Death of Board Member Eric Tiller
BRUNSWICK, Ga., June 21, 2024 (Newswire.com) – Torras Properties, Inc. announced today that C. Eric Tiller, Jr., a member of the Torras
Zillow says buyers need a 35% down payment instead of 20% to afford a typical home in 2024
Thinking about buying a home? You might be in for a rude awakening: a 20% down payment is no longer
A new startup from Figure’s founder is licensing NASA tech in a bid to curb school shootings
In 2013, there were 26 reported school shootings in the U.S. That figure rose to 82 a decade later. America
British Cyclist Breaks Leg Weeks Before 2024 Paris Olympics
Olympic Hopeful J.J. Rice Dead at 18 in Diving Accident For Katie Archibald, her 2024 Olympic dream ended before it
Sample Seed pitch deck: Feel Therapeutics’s $3.5M deck
Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable devices, mobile apps and clinician
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for